PI
BEAT

PEAK6 Investments’s BioTelemetry, Inc. BEAT Stock Holding History

PEAK6 Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-140,900
Closed -$10.2M – 5902
2020
Q4 		$10.2M Buy
140,900
+65,700
+87% +$3.44M 0.02% 667
2020
Q3 		$3.43M Sell
75,200
-6,300
-8% -$263K 0.01% 1227
2020
Q2 		$3.68M Buy
81,500
+15,700
+24% +$703K 0.01% 1014
2020
Q1 		$2.53M Buy
65,800
+41,100
+166% +$1.89M 0.01% 877
2019
Q4 		$1.14M Buy
+24,700
New +$1.07M 0.01% 1439
2019
Q3 		– Sell
-3,100
Closed -$149K – 4612
2019
Q2 		$149K Sell
3,100
-62,800
-95% -$3.3M ﹤0.01% 3001
2019
Q1 		$4.13M Sell
65,900
-32,300
-33% -$2.22M 0.02% 813
2018
Q4 		$5.87M Sell
98,200
-6,600
-6% -$396K 0.04% 557
2018
Q3 		$6.75M Buy
+104,800
New +$5.85M 0.03% 632

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

PEAK6 Investments's BEAT Position: Q4 2020 in Review

PEAK6 Investments sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 6,910 shares — an estimated $362K sold.

PEAK6 Investments first reported a position in BEAT in Q3 2019 and held it in 4 quarters. The position peaked at $3.3M in Q2 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • PEAK6 Investments reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • PEAK6 Investments sold 6,910 BioTelemetry, Inc. shares in Q4 2020, an estimated $362K.
  • PEAK6 Investments first reported a position in BioTelemetry, Inc. in Q3 2019 and held it in 4 quarters.
  • PEAK6 Investments's BioTelemetry, Inc. position peaked at $3.3M in Q2 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on PEAK6 Investments's 13F filing for Q4 2020, filed 12 Feb 2021.